Board of Directors

Welcome to the Consort Medical team.

Dr Peter Fellner

Chairman

Current roles:
Dr Fellner is currently Chairman of Vernalis plc, Optos plc, and Biotie Therapies Corp. and Vice Chairman of Astex Pharmaceuticals, Inc. He is also a director of the global biopharmaceutical company UCB SA and a member of the Novo A/S Advisory Group.

Dr Fellner is Chairman of the Nomination Committee at Consort Medical plc.

Past roles and experience:
Dr Fellner previously served as Chairman of Celltech Group plc from 2003 to July 2004, having been CEO from 1990 onwards. Before joining Celltech he was CEO of Roche UK from 1986 to 1990. More recently he served as Chairman of Acambis plc from 2006 until its acquisition by Sanofi Aventis in 2008 and of Premier Research Group plc from 2007 to 2008, when it was acquired by a private-equity backed group. Dr Fellner also served as a director of QinetiQ Group plc and Evotect AG.

Dr Fellner has many years' experience in the pharmaceutical and biotechnology industry in a variety of roles including R&D and senior executive and non-executive positions.

Jonathan Glenn

Chief Executive Officer

Current roles:
Chief Executive Officer.

Jonathan is a member of the Nomination Committee and the Corporate Responsibility Committee.

Past roles and experience:
Jonathan was Group Finance Director of Consort Medical plc from September 2006 to December 2007 until he took up the position of Chief Executive Officer in December 2007. Prior to joining Consort Medical plc, Jonathan was global Head of Finance at Celltech Group plc and later Chief Financial Officer of Akubio Ltd, a Cambridge-based developer of instrumentation for the Life Sciences industry.

Jonathan is a member of the Institute of Chartered Accountants in England and Wales.

Richard Cotton

Chief Financial Officer

Current roles:
Chief Financial Officer.

Past roles and experience:
From 2008 to 2011 Richard was Group Finance Director of Vitec Group plc, a photographic and video ancillary equipment provider. From 2005 to 2008 he was Group Finance Director at Wagon plc and from 2001 to 2005 Group Finance Director of McLeod Russell plc. Prior to this Richard held senior finance roles in Alcoa Europe and British Aluminium.

Richard is a Chartered Management Accountant.

Steve Crummett

Non-Executive Director

Current roles:
Finance Director of Morgan Sindall Group plc.

Steve is Chair of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee at Consort Medical plc.

Past roles and experience:
Previously Steve was Group Finance Director of Filtrona plc from 2008 to 2012. From 2003 to 2006 Steve was Group Director, Mergers & Acquisitions of the FTSE 100 company Exel plc.

Steve is a Chartered Accountant.

Ian Nicholson

Non-Executive Director

Current roles:
Ian is also Chairman of Bioventix Ltd, a diagnostics company, Chief Executive Officer of F2G Ltd, a UK-based antifungal drug discovery and development company. He is also a non-executive director of Clinigen Group plc, a specialty pharmaceuticals and services business, and also an operating partner at Advent Life Sciences.

Ian is Chair of the Corporate Responsibility Committee and a member of the Audit Committee, the Remuneration Committee and the Nomination Committee at Consort Medical plc.

Past roles and experience:
From 2004 to 2012 Ian was Chief Executive of Chroma Therapeutics Limited, a drug discovery and development company and from 2000 to 2004 Senior Vice President, Business Development at Celltech Group plc, then the UK's largest biotechnology company.

Ian has extensive experience in licensing, mergers and acquisitions and market development in the UK, Europe and the US.

Dr William Jenkins

Non-Executive Director

Current roles:
Principal of William Jenkins Pharma Consulting.

William is also a member of the Scientific Advisory Board of BB Biotech Ventures and Evotec AG & a member of the Strategic Advisory Board of Chiesi Farmaceutici SpA.

William is Chair of the Remuneration Committee and a member of the Nomination Committee.

Past roles and experience:
Formerly Head of Worldwide Clinical Development and Regulatory Affairs for Novartis Pharma AG. He held similar positions with Ciba Geigy AG and Glaxo.

William has been advising a wide range of pharma and biotech companies and investment and venture capital firms in the healthcare sector since 1999.

Dr Lynn Drummond

Non-Executive Director

Current roles:
Lynn is the non-executive Chairman of InFirst Healthcare Limited, a consumer healthcare company. She is also a non-executive director of Allocate Software plc, the leading workforce optimisation and compliance software applications provider for organisations with large, multi-skilled workforces and Shield Holdings AG, a speciality mineral medicines pharmaceutical company.

Lynn is a member of the Audit Committee and of the Nomination Committee at Consort Medical plc.

Past roles and experience:
Lynn was previously a managing director at Rothschild and her focus was on advising clients within the healthcare sector. Prior to this she worked in the UK Government Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. She is a Fellow of the Royal Society of Edinburgh and the Royal Society of Chemistry.